Click here if you are having trouble viewing this message.
Cell and Gene Therapy Catapult logo
April newsletter
On Monday 23rd April, Business Secretary Greg Clark and Science Minister Sam Gyimah opened our large-scale GMP manufacturing centre in Stevenage. 
The ministers were then given a tour of the state-of-the-art GMP manufacturing centre and had the opportunity to speak with our collaborators Adaptimmune, Autolus, Cell Medica, Freeline, Thermo Fisher Scientific and Asymptote about their involvement.

You can read more about the centre and how it plans to accelerate growth of the UK industry in our press release. You can also see photo and video highlights from the day in this article. 
Share this email on social media
 
News
CGT Catapult opens manufacturing centre
Business Secretary Greg Clark and Science Minister Sam Gyimah officially opened centre to ‘bridge the gap’ between scientific research and commercialisation
Read the press release
ReNeuron wins grant for retinal cell therapy development
ReNeuron is the lead industry participant in a new £1.5 million grant award from the UK’s innovation agency, Innovate UK, to advance development of its hRPC stem cell therapy.
More from ReNeuron
Ministers visit CGT Catapult manufacturing centre
On Monday 23 April Business Secretary Greg Clark and Science Minister Sam Gyimah were then given a tour of the state-of-the-art GMP manufacturing centre
See highlights from the event
Regulatory news from around the world
Keep up to date with regulatory news the EMA, MHRA and FDA including the EMA workshop on paediatric regulation and UK guidance on ‘GxP’ data integrity and definitions.
More regulatory news
 
Events
02 May
ISCT 2018
The ISCT 2018 Annual Meeting is being held at Palais des Congrès de Montréal, May 2-5, 2018. Cell and Gene Therapy Catapult will be attending ISCT 2018 and taking part in the following sessions:

Saturday 5th May 2018, 11:00-12:00
Growing the Pie: Has Investor Interest Increased for CGT post-approval of Kymriah, Yescarta and Luxturna?
Matthew Durdy, Chief Business Officer

More information on ISCT 2018

16 May
World Advanced Therapies & Regenerative Medicine Congress
13th World Advanced Therapies & Regenerative Medicine Congress will bring together 800+ attendees and explore the rapidly developing world of ATMPs. Cell and Gene Therapy Catapult will be in attendence and will be taking part in the following sessions:
 

Wednesday 16th May 2018, 10:00
Anticipating the technologies and infrastructure to mainstream ATMPs in the clinic
Keith Thompson, Chief Executive Officer

Wednesday 16th May 2018, 14:30                                                                       
Regulation, reimbursement & commercialisation of advanced therapies around the globe
Matthew Durdy, Chief Business Officer

More information on World Advanced Therapies & Regenerative Medicine Congress

30 May
Automation SIG
The automation SIG is a unique blend of truly immersive brainstorming sessions and innovate, activity-based networking designed to deliver a roadmap to cost-effective, robust and interconnected  manufacturing and supply chain models.
​​​​​​​
More information on the Automation SIG
 
Contact us
+44 (0) 203 728 9500
12th Floor Tower Wing, Guy’s Hospital, Great Maze Pond, London SE1 9RT